Last reviewed · How we verify
NCT03957070
The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis
NA trial testing Liver Incyte in Liver Fibrosis in 140 participants. Completed in 1 April 2021.
1 April 2021
Quick facts
| Lead sponsor | Sonic Incytes |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 140 |
| Start date | 1 February 2019 |
| Primary completion | 1 April 2021 |
| Estimated completion | 1 April 2021 |
| Sites | 2 locations across Canada, United States |
Drugs / interventions tested
- Liver Incyte
Conditions studied
- Liver Fibrosis — all drugs for Liver Fibrosis →
- Liver Steatosis — all drugs for Liver Steatosis →
Sponsor
Sonic Incytes
Who can join
Adults 19 to 75, any sex, with Liver Fibrosis or Liver Steatosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluate the feasibility of the Liver Incyte system for liver elasticity measurement in healthy volunteers and patients with liver fibrosis. To evaluate the discriminatory ability of elasticity measurements generated by Liver Incyte for healthy volunteers versus patients with liver fibrosis in comparison to FibroScan measurements.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.
Curry MP, Tam E, Schneider C, Abdelgelil N, et al · · 2024 · cited 2× · PMID 38274398 · DOI 10.1155/2024/8877130
Verify or expand the search:
- PubMed search for NCT03957070
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Fibrosis
Currently open trials in the same condition.
- NCT07031089 — City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the · recruiting
- NCT06940375 — Incidence of Liver Disease-Related Outcomes in People With HIV · recruiting
- NCT07271576 — Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis · NA · recruiting
- NCT07069725 — The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Partic · Phase 1 · recruiting
- NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
Other Sonic Incytes trials
Trials by the same sponsor.
- NCT04682600 — The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03957070 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sonic Incytes
- Last refreshed: 8 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957070.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing